Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

SideChannel Inc. (SDCH), Virgin Voyages Extend Engagement, Adding Virtual Chief Privacy Officer Services to Help Safeguard Data and Information

A recent study by IBM Corp. (NYSE: IBM) revealed that the average cost of a data breach in the hospitality industry was $2.94 million in 2022, down from $3.03 million in 2021. This cost, the study highlights, encompasses detection and escalation costs (covering forensic and investigative activities, assessment and audit services, crisis management, and communications […]

Lexaria Bioscience Corp. (NASDAQ: LEXX) Encouraged by Positive Findings from its DIAB-A22-1 Animal Model Study on Potential DehydraTECH-CBD(TM) Treatment for Diabetes

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced the completion of its DIAB-A22-1 animal model study, which explored the potential of the patented DehydraTECH(TM)-processed CBD to treat diabetes. Of note were three positive outcomes, including an improvement in general activity, reductions in body weight, and better triglyceride and cholesterol levels. […]

Silo Pharma Inc. (NASDAQ: SILO) Set to Benefit as Study Supports the Efficacy of Psychedelics in Treating ‘Drug-Resistant’ Depression

In a study carried out between 2013 to 2016, researchers found that 8.1% of American adults aged 20 and over suffered from depression during any given 2-week period, with women nearly twice as likely than men to have had acute depression (https://ibn.fm/ygq4x). Whilst depression has long been treated with a combination of self-help, talking therapies […]

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Leverages Top-Tier Leadership and GMP Facility to Advance Rapid Development of New Therapeutic and Prophylactic Technologies for Multiple Diseases and Disorders

Leveraging top-tier pharmaceutical industry leadership, extensive drug development expertise, a GMP biologics manufacturing facility, and strategic collaborations with Max Planck Institute for Multidisciplinary Sciences (“MPI”) and the University Medical Center Göttingen (“UMG”), BiondVax Pharmaceuticals (NASDAQ: BVXV) is aggressively advancing development of a pipeline of diversified, commercially viable “NanoAb” products and platforms. The Jerusalem, Israel-headquartered biopharmaceutical […]

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) subsidiary McEwen Copper adds $30 Million Boost from Nuton LLC to recent Stellantis investment of $155 Million, Plans for subsidiary IPO

The strength of metals explorer McEwen Copper’s profile and of its parent company McEwen Mining (NYSE: MUX) (TSX: MUX) was further demonstrated recently by a second investment of $30 million, at $18.75 per share  boost to an investment made by mining and metals giant Rio Tinto’s venture Nuton LLC. Nuton first invested $25 million last […]

Cybersecurity vCISO Provider SideChannel Inc. (SDCH) Meets Investors, Addresses Company Operations, in Investor Day Webcast

An Investor Day webcast event hosted by cybersecurity services and technology provider SideChannel (OTCQB: SDCH) provided insights on the company in a virtual meeting place that addressed the company’s history, its products, its financial position, its strategies for the future and introduced some of officers and board members for those investigating SideChannel’s potential. The live […]

Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Additional Findings From Human Clinical Study, Demonstrating DehydraTECH(TM)-CBD Effects on Hypertension

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced additional findings from its human clinical study HYPER-H21-4, demonstrating a potentially novel mechanism of action of its patented DehydraTECH(TM)-processed cannabidiol (“CBD”) capsule formulation in reducing blood pressure. The FDA lays out clear guidelines for sponsors seeking to develop new anti-hypertension drugs, specifically […]

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) Pushes for a Net Zero Future with Carbon-Neutral RNG

EverGen Infrastructure (TSX.V: EVGN) (OTCQX: EVGIF) is focused on achieving a Net-Zero future by leveraging the power of renewable natural gas (“RNG”) – a carbon-neutral alternative to natural gas that is compatible with existing pipeline infrastructure. RNG is carbon-negative since it is produced from organic materials that would otherwise decompose and generate methane emissions. By […]

 

From Our Blog

Mobilicom Ltd. (NASDAQ: MOB) Builds on $2.2 Million in Orders with Pipeline of Nine Tier-1 Design Wins Globally

November 9, 2026

Autonomous drones and other unmanned systems depend on several interconnected technologies to carry out their intended missions. Communications links connect platforms with operators, onboard systems execute mission instructions, and reliable data supports operational decision-making. As military organizations continue to rely on these technologies, protecting the systems and connections supporting autonomous operations is becoming an important […]

Rotate your device 90° to view site.